Torsten Madsen, MD, PhD

    Chief Medical Officer, Aptinyx

    Torsten M. Madsen, M.D., Ph.D., has served as Chief Medical Officer at Aptinyx, Inc, since July 2015. He previously served as Vice President and an observer on the board of directors of Naurex Inc. and was prior to that  Chief Medical Officer and Vice President of U.S. drug development at Lundbeck from January 2014 to April 2015. Prior to this, Dr. Madsen served in different roles at H. Lundbeck A/S between 2006 and 2013, including as Division Director of international clinical research in mood and anxiety disorders, directing the clinical development program and registration of vortioxetine. Before joining Lundbeck, Dr. Madsen was a resident physician in psychiatry at Aarhus University Hospital in Denmark. Dr. Madsen received an M.D. and a Ph.D. from Copenhagen University and worked as a postdoctoral associate in the Department of Molecular Psychiatry at Yale University